THE EFFECT OF AN INTRALESIONAL SUSTAINED-RELEASE FORMULATION OF INTERFERON ALFA-2B ON BASAL-CELL CARCINOMAS

被引:46
作者
EDWARDS, L
TUCKER, SB
PEREDNIA, D
SMILES, KA
TAYLOR, EL
TANNER, DJ
PEETS, E
机构
[1] UNIV TEXAS,SCH MED,HOUSTON,TX 77025
[2] SCHERING PLOUGH CORP,KENILWORTH,NJ
关键词
D O I
10.1001/archderm.126.8.1029
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1029 / 1032
页数:4
相关论文
共 11 条
[1]  
EDWARDS L, 1986, ARCH DERMATOL, V122, P79
[2]  
GOLDSTEIN D, 1986, CANCER RES, V46, P4315
[3]   TREATMENT OF BASAL-CELL CARCINOMA WITH INTRALESIONAL INTERFERON [J].
GREENWAY, HT ;
CORNELL, RC ;
TANNER, DJ ;
PEETS, E ;
BORDIN, GM ;
NAGI, C .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (03) :437-443
[4]   EFFECT OF HUMAN RECOMBINANT INTERFERON ON CYTO-TOXIC ACTIVITY OF NATURAL-KILLER (NK) CELLS AND MONOCYTES [J].
HERBERMAN, RB ;
ORTALDO, JR ;
MANTOVANI, A ;
HOBBS, DS ;
KUNG, HF ;
PESTKA, S .
CELLULAR IMMUNOLOGY, 1982, 67 (01) :160-167
[5]  
IRIC D, 1981, LANCET, V1, P1025
[6]  
KRONENBERG LH, 1982, ANN INTERN MED, V96, P80
[7]  
PESTKA S, 1986, SEMIN HEMATOL, V23, P27
[8]  
Rosa F M, 1986, Interferon, V7, P47
[9]  
SCHULTZ RM, 1980, LYMPHOKINE REP, V1, P63
[10]  
SMALLEY RV, 1986, SPRINGER SEMIN IMMUN, V9, P73